Amgen, Inc. (AMGN)
467.06
-1.05
(-0.22%)
USD |
NASDAQ |
Nov 12, 16:00
467.93
+0.87
(+0.19%)
After-Hours: 07:42
Amgen Total Liabilities (Quarterly) : 81.70B for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 81.70B |
| June 30, 2026 | 83.95B |
| March 31, 2026 | 83.31B |
| December 31, 2025 | 81.93B |
| September 30, 2025 | 80.52B |
| June 30, 2025 | 80.47B |
| March 31, 2025 | 83.16B |
| December 31, 2024 | 85.96B |
| September 30, 2024 | 83.36B |
| June 30, 2024 | 84.98B |
| March 31, 2024 | 87.96B |
| December 31, 2023 | 90.92B |
| September 30, 2023 | 82.88B |
| June 30, 2023 | 83.49B |
| March 31, 2023 | 83.37B |
| December 31, 2022 | 61.46B |
| September 30, 2022 | 60.05B |
| June 30, 2022 | 56.88B |
| March 31, 2022 | 58.28B |
| December 31, 2021 | 54.46B |
| September 30, 2021 | 56.78B |
| June 30, 2021 | 51.53B |
| March 31, 2021 | 53.20B |
| December 31, 2020 | 53.54B |
| September 30, 2020 | 53.68B |
| Date | Value |
|---|---|
| June 30, 2020 | 54.35B |
| March 31, 2020 | 52.18B |
| December 31, 2019 | 50.03B |
| September 30, 2019 | 48.61B |
| June 30, 2019 | 48.58B |
| March 31, 2019 | 53.16B |
| December 31, 2018 | 53.92B |
| September 30, 2018 | 52.98B |
| June 30, 2018 | 52.78B |
| March 31, 2018 | 55.54B |
| December 31, 2017 | 54.71B |
| September 30, 2017 | 48.10B |
| June 30, 2017 | 47.86B |
| March 31, 2017 | 47.22B |
| December 31, 2016 | 47.75B |
| September 30, 2016 | 47.38B |
| June 30, 2016 | 45.34B |
| March 31, 2016 | 46.43B |
| December 31, 2015 | 43.49B |
| September 30, 2015 | 43.90B |
| June 30, 2015 | 43.72B |
| March 31, 2015 | 42.45B |
| December 31, 2014 | 43.23B |
| September 30, 2014 | 45.45B |
| June 30, 2014 | 45.15B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 38.45B |
| Regeneron Pharmaceuticals, Inc. | 10.91B |
| AbbVie, Inc. | 152.22B |
| Biogen, Inc. | 13.13B |
| Vertex Pharmaceuticals, Inc. | 11.83B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.05B |
| Shareholders Equity (Quarterly) | 14.35B |
| Debt to Equity Ratio | 3.763 |
| Current Ratio | 1.479 |
| Net Debt Paydown Yield | 0.19% |